Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ISOSORBIDE MEDISOL (isosorbide dinitrate)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ISOSORBIDE MEDISOL (isosorbide dinitrate)

Medicine - Posted on Mar 29 2017 - Updated on Jun 12 2019
Active substance (DCI)
  • isosorbide dinitrate
history (2)
  • 3/22/17

    ISOSORBIDE MEDISOL (isosorbide dinitrate)

    Mise à disposition d'un générique de RISORDAN
    CAV :
    54321
    icône flèche
  • 7/20/05

    ISOSORBIDE TEVA LP 60 mg, gélule à libération prolongée (Boîte de 30 (code CIP : 361 135-9))

    ISOSORBIDE TEVA LP 60 mg, gélule à libération prolongée (Boîte de 30 (code CIP : 361 135-9))
    icône flèche
Technical information
ATC code
  • C01DA08
Manufacturer
MEDISOL
Presentation

ISOSORBIDE MEDISOL 10 mg/10 ml, solution injectable (code CIS : 64766264) Solution injectable, ampoule de 10 ml (B50) - Code CIP : 3400955028833

All our publications
    Drug therapy Heart failure Myocardial ischemia Pain - Inflammation Pulmonary and pleural diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
akb53Eh7fcmd4Spu